Crescita Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Crescita Therapeutics has a total shareholder equity of CA$18.1M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$24.1M and CA$5.9M respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
Interest coverage ratio | n/a |
Cash | CA$9.53m |
Equity | CA$18.14m |
Total liabilities | CA$5.93m |
Total assets | CA$24.07m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CRRT.F's short term assets (CA$18.4M) exceed its short term liabilities (CA$5.1M).
Long Term Liabilities: CRRT.F's short term assets (CA$18.4M) exceed its long term liabilities (CA$804.0K).
Debt to Equity History and Analysis
Debt Level: CRRT.F is debt free.
Reducing Debt: CRRT.F has no debt compared to 5 years ago when its debt to equity ratio was 22.9%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable CRRT.F has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: CRRT.F is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 7% per year.